NCT05288439
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 6 Years to 21 Years (Child, Adult))
Location of Metastases: Brain
Additional Notes: Patients must be recommended to receive whole-brain proton beam radiation therapy (PBRT)
Exclusions: Patients not between the ages of 6 through 21
https://ClinicalTrials.gov/show/NCT05288439